Market Analysis

Healthtech VC Funding Surges: Ambience & OpenEvidence Set New AI Valuation Standards

Leave a Comment / Artificial Intelligence, Funding Trends, HealthTech, Market Analysis, Startup Valuations, Venture Capital / By
Healthtech venture funding rebounded in 2025, with capital through...

Ambience Healthcare raised a $243 million Series C at a roughly $1...

OpenEvidence secured a $210 million Series B at a $3.5 billion val...

Investors are prioritizing “practical” workflow and administra...

Valerie Health Raises $39M to Power AI Platform for Independent Physician Practices

Leave a Comment / AI in Healthcare, Funding News, Healthcare Tech, Independent Practices, Market Analysis, Startup Growth / By
Valerie Health, founded in 2024, raised $30 million in Series A fu...

The startup automates front-office tasks like referrals, schedulin...

Clients report 5–7% higher patient volumes, while Valerie’s re...

Valerie targets independent practices to support provider autonomy...

Why Private Equity Pros Are Fleeing Big Firms for Smaller, Specialized Funds

Leave a Comment / Career Transitions, Financial analysis, Fund Performance, Investment Trends, Market Analysis, Market Insights, Private Equity / By
Mid-level professionals are increasingly leaving large private-equ...

Higher interest rates and weak exit activity since 2022 have under...

Smaller and specialist funds often offer faster promotion, greater...

Performance data showing smaller and sector-focused funds outperfo...

Goldman Sachs Reclaims Global M&A Lead in 2025 With $432.3B in Mega Deals

Leave a Comment / Financial Markets, Goldman Sachs, Investment Banking, Market Analysis, Mergers and Acquisitions, Sector Performance / By

<div class="section-block section-executivesummary”> Gist Goldman Sachs has reclaimed the top global M&A adviser spot by deal value in 2025, capturing about 34% of announced worldwide deal value, its highest share since 2015. From Q1–Q3 2025 it advised on roughly $432 billion of deals, including 84 transactions of at least $1 billion, prioritizing mega-deals over high-volume …

Goldman Sachs Reclaims Global M&A Lead in 2025 With $432.3B in Mega Deals Read More »

Warner Bros. Discovery takeover fight: Paramount’s $30 vs Netflix’s $27.75 per share

Leave a Comment / Corporate Strategy, Entertainment Industry, Market Analysis, Mergers and Acquisitions, Regulatory Issues / By
Warner Bros. Discovery faces competing bids: an all-cash US$30/sha...

Paramount’s bid, backed by Ellison, RedBird, major US banks, and...

Netflix’s narrower bid excludes WBD’s linear networks, aiming ...

WBD’s board is running a broader strategic review, weighing thes...

Morgan Stanley’s Q3 Momentum: Beating Goldman Sachs in Equities & IB, GS Holds Value Edge

Leave a Comment / Equities trading, Financial Performance, Goldman Sachs, Investment Banking, Market Analysis, Morgan Stanley / By
Morgan Stanley’s Q3 2025 results showed faster growth in revenue...

Goldman delivered strong earnings, leading investment banking fees...

Valuation favors Goldman with a lower price-to-tangible-book, whil...

Both banks cleared Fed stress tests and announced large buybacks, ...

Goldman & Morgan Stanley Warn of 10–20% Market Correction — Asia Poised as Growth Haven

Leave a Comment / Asia Growth Opportunities, Economic Forecasts, Equity Markets, Investment Strategies, Market Analysis / By
Goldman Sachs and Morgan Stanley CEOs expect a normal but sizable ...

The IMF warns that stretched valuations, high government deficits,...

Despite caution, major banks advise investors to stay invested, st...

Asia, particularly China, Hong Kong, Japan, and India, is highligh...

Jefferies Leverages SMBC Alliance To Boost Advisory & Investment Banking Growth

Leave a Comment / Cross-border Transactions, Equity Financing, Financial Performance, Investment Banking, Market Analysis, strategic alliances / By
Jefferies has deepened its strategic alliance with SMBC, which now...

This partnership boosts Jefferies’ balance sheet and reach in le...

Investment banking performance has accelerated, with fiscal 2024 f...

Key risks include weak and volatile equity underwriting, choppy as...
Scroll to Top